Current and Possible Future Therapeutic Options for Huntington’s Disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125092/
WEBMay 21, 2022 · These categories include chorea medication, antipsychotic medication, antidepressants, mood stabilizing medication as well as non-drug therapies. Fortunately, there are also many new HD therapeutics currently undergoing clinical trials that target the disease at its origin; lowering the levels of mutant huntingtin protein (mHTT).
DA: 91 PA: 33 MOZ Rank: 52 Up or Down: Up